Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Eden Research plc (EDL)

  Print      Mail a friend

Friday 16 April, 2010

Eden Research plc

Submission of DAR for 3AEY by CRD

                                                                                              16 April 2010

                                             EDEN RESEARCH PLC
                                           ("Eden" or "Company")

                                     Submission of DAR for 3AEY by CRD

Eden Research plc, a leading UK agrochemical development company, today announces that it has been informed
by  the Chemicals Regulation Directorate ("CRD") that the review of the Draft Assessment Report ("DAR") for
the  Company's lead product, 3AEY, and its three active components, has been completed and submitted to the
European Foods Safety Authority ("EFSA"). The CRD has recommended that Eden undertakes an additional  assay
study  as  some  EU member states may require it for national approval and, in order to expedite  sales  of
Eden's product, this will be done in the next few months.

The  submission  of  the DAR to EFSA triggers a milestone payment of £38,000 by one  of  Eden's  licensees,
Environmental Solutions North Africa Limited, under the licensing agreement.

The completion of the review by CRD is a major step forward in the route to full commercialisation of 3AEY,
a  terpene  based  fungicide. Terpenes are natural compounds which function as defence mechanisms  in  many
plant  groups and are released in response to infection, stress or mechanical injury. Their natural disease
control  has  been  acknowledged for some time, but it is Eden's unique patented encapsulation  process  of
3AEY, which allows the slow release of terpenes, that forms the revolutionary aspect of this treatment. The
specific application covered by the DAR is for the control of the fungal disease, botrytis, in grape vines.

Botrytis  is  a widespread fungal problem that causes "grey mould" on fruits and vegetables, often  arising
late  in  the  growing cycle and leading to the rapid reduction in marketable yield and  lower  quality  of
crops.  Annual worldwide expenditure on fungicides to control botrytis is typically c.$300m.

The  announcement  of  this "green" development is especially important and timely as  the  new  regulatory
controls  on EU pesticides are expected to significantly reduce the already diminished arsenal  of  control
chemicals available to farmers and growers.

Once  the  DAR  is received by EFSA, the process of gaining national registrations for sale  can  commence.
Prior  to full EU approval, individual countries may issue 'provisional approval' for use. Such provisional
approval,  subject  to  the  territory,  would allow sales of 3AEY to  begin  through  Eden's  existing  EU
licensees.  It will also benefit our current licensees in other territories, particularly in  North  Africa
(Environmental Solutions) and East Africa (Lachlan Kenya) where crops are being grown for export to the EU.

Clive Newitt, Managing Director of Eden Research, said:

"The submission of the DAR represents a major milestone in the approval process for our lead product, 3AEY.
This  not  only paves the way for the commercialisation of 3AEY, but also provides a very firm footing  for
the registration of further products from our pipeline as they are based upon the same active substances in
different combinations and ratios.

Our products offer viable alternative methods of controlling damaging pests and diseases which can be fully
incorporated into Integrated Crop Management programmes and thereby minimise future resistance problems."

The directors of Eden Research plc are responsible for the contents of this announcement.


Eden Research plc                                                        01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                           020 7368 6959
Mark Anwyl

Threadneedle Communications                                              020 7653 9850
Josh Royston
Beth Harris

Eden Research plc

a d v e r t i s e m e n t